Get the Stockscreener App
14.11
0.21%
0.03
After Hours:
13.83
-0.28
-1.98%
Surgery Partners Inc stock is traded at $14.11, with a volume of 1.94M.
It is up +0.21% in the last 24 hours and up +5.06% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$14.08
Open:
$13.88
24h Volume:
1.94M
Relative Volume:
1.13
Market Cap:
$1.83B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-52.26
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-8.20%
1M Performance:
+5.06%
6M Performance:
-37.32%
1Y Performance:
-41.13%
1-Day Range:
$13.73
$14.19
1-Week Range:
$12.25
$15.90
52-Week Range:
$12.25
$24.64
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
14.11 | 1.82B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
534.47 | 121.74B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
241.40 | 21.29B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.05 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
207.30 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
196.96 | 12.36B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
TD Cowen Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $20.00 - MarketBeat
SGRY Stock: TD Cowen Lowers Price Target to $20.00, Maintains Bu - GuruFocus
Analyst Expectations For Surgery Partners's Future - Benzinga
UBS Group Issues Pessimistic Forecast for Surgery Partners (NASDAQ:SGRY) Stock Price - MarketBeat
UBS Maintains 'Buy' Rating for Surgery Partners (SGRY), Lowers P - GuruFocus
UBS Adjusts Price Target on Surgery Partners to $21 From $29, Maintains Buy Rating - marketscreener.com
SGRY: Mizuho Lowers Price Target to $17, Maintains Outperform Ra - GuruFocus
Surgery Partners (NASDAQ:SGRY) Price Target Cut to $17.00 by Analysts at Mizuho - MarketBeat
Assessing Surgery Partners (SGRY) Valuation After Recent Share Price Weakness And Undervalued Narrative - simplywall.st
Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25 - Markets Mojo
Surgery Partners Faces Weak Start with 21.85% Gap Down Amid Market Concerns - Markets Mojo
Jefferies Maintains Buy on Surgery Partners (SGRY) March 2026 - Meyka
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS - Finviz
Inside Surgery Partners' push into a $6B dialysis access business - Stock Titan
Benchmark cuts Surgery Partners stock price target on weak guidance By Investing.com - Investing.com Canada
Jefferies cuts Surgery Partners stock price target on earnings reset By Investing.com - Investing.com Canada
Custom Surgical Partners & Ambulatory Strategies Unite: Decades of ASC Expertise - PR Newswire
Surgery Partners, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
RBC Cuts Price Target on Surgery Partners to $20 From $31, Keeps Outperform Rating - marketscreener.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2025 Earnings Call Transcript - Insider Monkey
Deals tracker: MUSC Health acquires primary care physician group - Modern Healthcare
SGRY Financials: Income Statement, Balance Sheet & Cash Flow | Surgery Partners Inc - Stock Titan
Benchmark Maintains Buy on Surgery Partners (SGRY) March 3, 2026 - Meyka
Surgery Partners' Plunge Offers An Opportunity For Upside (Rating Upgrade) - Seeking Alpha
Surgery Partners (SGRY -12%): Weak Guidance, Q4 EBITDA Miss Drive Sell-Off - Trefis
Surgery Partners stock hits 52-week low at $12.47 By Investing.com - Investing.com Canada
Surgery Partners Earnings Call Balances Growth And Strain - TipRanks
Surgery Partners Inc (SGRY) Q4 2025 Earnings Call Highlights: Re - GuruFocus
Surgery Partners Q4 Earnings Call Highlights - MarketBeat
SGRY: Barclays Maintains Rating, Lowers Price Target to $14.00 | - GuruFocus
Commit To Buy Surgery Partners At $7.50, Earn 48.7% Annualized Using Options - Nasdaq
Benchmark reiterates Surgery Partners stock rating citing payor mix headwinds - Investing.com Canada
Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $14.00 at Barclays - MarketBeat
Surgery Partners (NASDAQ:SGRY) Reaches New 12-Month Low Following Weak Earnings - MarketBeat
Surgery Partners stock hits 52-week low at $12.47 - Investing.com
Surgery Partners, Inc. (SGRY) Stock Analysis: A 60% Upside Potential Amidst Healthcare Growth - DirectorsTalk Interviews
Surgery Partners, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-03-03 - Seeking Alpha
Surgery Partners, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vanguard Group Inc. Acquires 424,518 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Surgery Partners Stock Hits 52-Week LowHere's Why - Benzinga
Surgery Partners reports Q4 revenue rise, cuts full-year outlook By Investing.com - Investing.com India
Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com South Africa
Decoding Surgery Partners Inc (SGRY): A Strategic SWOT Insight - GuruFocus
Is Surgery Partners’ 2025 Revenue Growth And Narrowing Loss Reshaping The Investment Case For SGRY? - simplywall.st
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million - AOL.com
Surgery Partners Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Surgery Partners Announces Share Buyback and 2026 Outlook - TipRanks
Surgery Partners's (NASDAQ:SGRY) Q4 CY2025: Beats On Revenue But Stock Drops 18% - Finviz
Surgery Partners (SGRY) Lags Q4 Earnings Estimates - Yahoo Finance
Surgery Partners (NASDAQ:SGRY) Issues Earnings Results, Misses Expectations By $0.19 EPS - MarketBeat
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):